146 related articles for article (PubMed ID: 3241323)
1. [In vitro susceptibilities of clinical isolates of Staphylococcus aureus].
Igari J; Shimoji K; Uezu N; Nakasone I; Taira K; Kakazu R
Jpn J Antibiot; 1988 Sep; 41(9):1205-11. PubMed ID: 3241323
[TBL] [Abstract][Full Text] [Related]
2. [Study on the drug sensitivity of multiple drug-resistant Staphylococcus aureus].
Deguchi K; Fukayama S; Nishimura Y; Yokota N; Tanaka S; Oda S; Matsumoto Y; Ikegami R; Satoh K; Toyonaga Y
Jpn J Antibiot; 1985 Aug; 38(8):2163-70. PubMed ID: 3852898
[TBL] [Abstract][Full Text] [Related]
3. [Antimicrobial activity of fosfomycin against beta-lactamase-producing methicillin-sensitive Staphylococcus aureus and methicillin-sensitive coagulase-negative staphylococci].
Hara T; Araake M; Tsuruoka T; Watabe H
Jpn J Antibiot; 2003 Apr; 56(2):142-7. PubMed ID: 12825415
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
Matsuo K; Tsuzaki Y; Furukawa S; Uete T
Jpn J Antibiot; 1984 Jun; 37(6):1040-57. PubMed ID: 6387213
[TBL] [Abstract][Full Text] [Related]
5. [A nationwide study of the antimicrobial susceptibility of clinical isolates of Staphylococcus aureus in Japan].
Igari J; Shitara M; Shitara S; Yoshimoto K; Hayashi Y; Kosakai N
Jpn J Antibiot; 1988 May; 41(5):485-93. PubMed ID: 3216471
[TBL] [Abstract][Full Text] [Related]
6. [Nationwide study of the antimicrobial susceptibility of clinical isolates of Proteus group in Japan].
Igari J; Shitara M; Morimoto M; Shiga N; Kosakai N
Jpn J Antibiot; 1987 Apr; 40(4):823-42. PubMed ID: 3475483
[TBL] [Abstract][Full Text] [Related]
7. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
[TBL] [Abstract][Full Text] [Related]
8. [Susceptibility and beta-lactamase-producing strains of methicillin-resistant Staphylococcus aureus].
Akimoto Y; Kaneko K; Fujii A
Nichidai Koko Kagaku; 1989 Sep; 15(3):338-41. PubMed ID: 2489806
[TBL] [Abstract][Full Text] [Related]
9. [Hospital and district differences in susceptibilities to antibiotics of main clinical isolates].
Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y; Suzuki A; Kudo H; Hayasaka N; Toyoshima S; Yamazaki Y
Jpn J Antibiot; 1990 Feb; 43(2):362-73. PubMed ID: 2194057
[TBL] [Abstract][Full Text] [Related]
10. [Antibacterial activities of various aminoglycosides against clinically isolated methicillin-resistant Staphylococcus aureus].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Sato K; Kato M
Jpn J Antibiot; 1987 Nov; 40(11):1941-5. PubMed ID: 3444031
[TBL] [Abstract][Full Text] [Related]
11. [Enhancement of in vitro antimicrobial activity of cefmetazole and cefazolin in combination against methicillin-resistant Staphylococcus aureus studies by checkerboard MIC method and disc diffusion method using discs containing both drugs].
Matsuo K; Uete T
Jpn J Antibiot; 1993 Feb; 46(2):130-41. PubMed ID: 8331773
[TBL] [Abstract][Full Text] [Related]
12. [Annual changes of sensitivities of Staphylococcus aureus to several antibiotics].
Kosakai N; Mori M; Shitara M; Kudo M; Morimoto M
Jpn J Antibiot; 1982 Aug; 35(8):1934-44. PubMed ID: 6961238
[TBL] [Abstract][Full Text] [Related]
13. [Susceptibilities of uropathogenic bacteria to ampicillin, cefazolin, cefmetazole and gentamicin. Nine-year survey of changing patterns of susceptibilities].
Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y
Jpn J Antibiot; 1990 Sep; 43(9):1530-7. PubMed ID: 2262960
[TBL] [Abstract][Full Text] [Related]
14. [Antibacterial activity of imipenem in combination with ampicillin against methicillin-resistant strains of Staphylococcus aureus].
Saionji K; Shitara M; Miyake N; Inoue K; Kobayashi I
Jpn J Antibiot; 1990 Oct; 43(10):1685-97. PubMed ID: 2086811
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
Matsuo K; Uete T
Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
[TBL] [Abstract][Full Text] [Related]
16. [In vitro susceptibility, of bacterial isolates from patients with respiratory tract infections, to beta-lactam antibiotics II].
Tanaka M; Otsuki M; Aoyagi M; Isotani S; Kawabata H; Moriguchi T; Nishino T; Tanino T; Nakanishi M; Maekawa N
Jpn J Antibiot; 1986 Nov; 39(11):2914-25. PubMed ID: 3820570
[TBL] [Abstract][Full Text] [Related]
17. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
[TBL] [Abstract][Full Text] [Related]
18. [Studies on phage type, beta-lactamase activity and sensitivity of multiple drug-resistant Staphylococcus aureus isolated from clinical specimens to cefmetazole].
Toyonaga Y; Kurosu Y; Sugita M; Kumagai K; Hori M; Hoshina S; Kurosaka K; Nishiyama H; Shinohara N; Takahashi T; Deguchi K 210 P
Jpn J Antibiot; 1982 Jul; 35(7):1673-85. PubMed ID: 6217356
[TBL] [Abstract][Full Text] [Related]
19. [Detection of causative bacteria for bovine mastitis and their susceptibility to beta-lactam antibacterial agents].
Kamata S; Matsunaga T; Uchida K; Uchida K
Jpn J Antibiot; 1990 Oct; 43(10):1698-712. PubMed ID: 2086812
[TBL] [Abstract][Full Text] [Related]
20. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
